CompletedNot Applicable

A Single-Session Intervention Fostering Emotional Nonreactivity

United States550 participantsStarted 2025-07-16

Plain-language summary

The purpose of this study is to evaluate the effectiveness of a novel online single-session intervention (SSI) designed to improve emotion regulation abilities in young adults (ages 18-29). The active intervention condition, titled "Project WAVE," uses mindfulness skills training and an emotion exposure to teach participants how to cope with distressing emotions. Project WAVE will be evaluated in comparison with another online activity that controls for nonspecific aspects of single-session interventions.

Who can participate

Age range

18 Years – 29 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* Between the ages of 18 and 29, inclusive * Self-report comfort in reading and writing in English * Have access to the Internet through computer, laptop, smartphone, etc. * Live in the United States or U.S. territories, per IP address * Provide an endorsement of either "disagree" or "strongly disagree" on at least one of the following three items adapted from the Nonreactivity subscale of the Five Facet Mindfulness Questionnaire: "I was aware of my feelings and emotions without having to react to them"; "I watched my feelings without getting lost in them"; "When I had distressing emotions, I 'stepped back' and was aware of the emotion without getting taken over by it" * Commit to providing thoughtful answers to the questions asked * Pass the attention check / bot detection question, "Are you taller than 10 feet?" ("yes," "no," or "unsure") in the initial screener survey Exclusion Criteria: * Fail to meet the above-listed inclusion criteria * Exit the study prior to condition randomization * Fail to pass data integrity measures

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Emotion Intolerance Beliefs.

Timeframe: Data will be collected in both conditions at all time points (pre-intervention, immediate post-intervention, and two-week follow-up).

Trial details

NCT IDNCT07034027

SponsorNorthwestern University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-05

View on ClinicalTrials.gov More Emotional Dysregulation trials